ten Berg J, Gerritsen W, Haas F, Kelder H, Verheugt F and Thijs Plokker H (2002) High-dose aspirin in addition to daily low-dose aspirin decreases platelet activation in patients before and after ...

The daily use of low-dose aspirin against heart disease may have taken another knock. New research shows that the practice may not provide the added benefit of reduced heart attack risk to Black ...

Our approach is based on SBE detection coupled with high-performance liquid chromatography (HPLC) quantification. To demonstrate the utility of our approach, we report data to determine the gene ...

ASCO 2025, bladder cancer, non-muscle invasive bladder cancer (NMIBC), High-Risk Non-Muscle-Invasive Bladder Cancer, Disitamab Vedotin ... 2023, and December 1, 2024, 9 patients were treated across ...

PHILADELPHIA – Catapult Learning, a division of FullBloom that provides intervention programs for students and professional development solutions for teachers in K-12 schools, today broadly announced ...

High-dose aspirin (HDA) is used with intravenous immunoglobulin (IVIg) in Kawasaki disease (KD). Practice regarding HDA varies, and it is unclear whether HDA duration affects the long-term course.

Introduction Pre-eclampsia is an important cause of death and complication for pregnant women and perinatal infant. Low-dose aspirin has been most commonly used to prevent pre-eclampsia in high-risk ...

Encapsulated metformin, but not free metformin, significantly inhibited the growth of PASMCs derived from either unaffected people or a woman with heritable PAH in a dose-dependent manner.. The ...

Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: a double blinded randomized ...

The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax ...

It’s made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target. The approval “adds an important new tool to help ...

This study aims to identify the efficacy of single low-dose 5mg versus 8mg dex with nepa for the 168h prevention of highly or moderately emetogenic (high-risk patients) CINV. Methods: This open-label, ...